CN Patent

CN102209543A — 用于具有非典型肝功能的患者的吡非尼酮治疗

Assigned to Intermune Inc · Expires 2011-10-05 · 15y expired

What this patent protects

提供了关于给响应吡非尼酮施用已显示出肝功能的异常生物标记的患者施用吡非尼酮的方法。该方法包括以低于完全靶剂量的剂量给患者施用吡非尼酮一段时间，随后以完全靶剂量给患者施用吡非尼酮。该方法还包括施用以完全靶剂量无减少的吡非尼酮，且施用永久减少剂量的吡非尼酮。

USPTO Abstract

提供了关于给响应吡非尼酮施用已显示出肝功能的异常生物标记的患者施用吡非尼酮的方法。该方法包括以低于完全靶剂量的剂量给患者施用吡非尼酮一段时间，随后以完全靶剂量给患者施用吡非尼酮。该方法还包括施用以完全靶剂量无减少的吡非尼酮，且施用永久减少剂量的吡非尼酮。

Drugs covered by this patent

Patent Metadata

Patent number: CN102209543A
Jurisdiction: CN
Classification: —
Expires: 2011-10-05
Drug substance claim: No
Drug product claim: No
Assignee: Intermune Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.